Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001470831-26-000504

Director acquired 1,070 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Anderson Kenneth Carl · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-06-01 Exercise or conversion : show line 1 in the form +1,070 $2.11 $2,258 69,300 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-01 Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) −1,070 0 D
Loading xslF345X06/wk-form4_1780604078.xml…